Xin-Qi Teng

机构：Central South University, Integrated Chinese Medicine (China), Wuhan No.1 Hospital, Second Xiangya Hospital of Central South University

发表论文 19 篇 · 总被引 444 次 · h-index 12

代表论文

• Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance (2021 · Journal of Experimental & Clinical Cancer Research · 被引 85)
• The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors (2023 · International Journal of Biological Sciences · 被引 61)
• The Burgeoning Significance of Liquid-Liquid Phase Separation in the Pathogenesis and Therapeutics of Cancers (2024 · International Journal of Biological Sciences · 被引 53)
• Clinical Analysis of Metagenomic Next-Generation Sequencing Confirmed Chlamydia psittaci Pneumonia: A Case Series and Literature Review (2021 · Infection and Drug Resistance · 被引 47)
• Individualized antibiotic dosage regimens for patients with augmented renal clearance (2023 · Frontiers in Pharmacology · 被引 34)
• Superenhancers as master gene regulators and novel therapeutic targets in brain tumors (2023 · Experimental & Molecular Medicine · 被引 24)